ArticleSurgical endoscopy2025
Protective effects of antireflux surgery on lung function in patients with interstitial lung disease.
Article in Surgical endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Analysis of cardiopulmonary function characteristics and related factors in patients with hiatal hernia.Hernia : the journal of hernias and abdominal wall surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundInterstitial lung disease (ILD) is a debilitating and progressive process whose etiology is not completely understood. Correlations between gastroesophageal reflux disease and ILD have been established, with studies suggesting that microaspiration of gastric contents may perpetuate the disease process. Early data suggest that antireflux surgery may prevent disease progression and decrease frequency of exacerbations. We hypothesize that antireflux surgery is safe and effective in patients with interstitial lung disease and that it may positively impact lung function.
methodsWe performed a retrospective review on prospectively collected data of all patients who underwent antireflux surgery in the setting of ILD at a single academic institution between 2021 and 2024. Primary endpoints include 30-day readmission, mortality, and postoperative complications. Secondary endpoints included postoperative reported reflux symptoms, and preoperative and postoperative pulmonary function tests.
resultsThirty-five (35) patients with a history of ILD underwent antireflux surgery. The majority of patients underwent robotic hiatal hernia repair with Toupet (270°) fundoplication. There were two 30-day readmissions. One patient required EGD with dilation for postoperative dysphagia. There were no mortalities at 1 year. The majority of patients (n = 26, 74%) reported complete resolution of reflux. Postoperative FVC values and percent predicted FVC were significantly higher than preoperative values (2.29 ± 0.8 versus 2.13 ± 0.6, p = 0.01) (65.4% ± 18 versus 61.3% ± 17, p = 0.001). Postoperative FEV1 levels were greater than preoperative levels (1.9 ± 0.6 versus 1.7 ± 0.5, p = 0.01). Percent predicted FEV1 also significantly improved after surgery (68.2% ± 20 versus 63.4 ± 19, p = 0.007). Post and preoperative DLCO remained unchanged (10.0 ± 2.4, 9.9 ± 2.8, p = 0.9).
conclusionRobot-assisted laparoscopic antireflux surgery appears to be a safe method for reflux control in patients with interstitial lung disease and can help to stabilize or even improve lung function at short-term follow-up.
Indexed as
Identifiers
40634723What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.